Dechra Pharmaceuticals PLC Director/PDMR Shareholding (3558N)
24 September 2019 - 1:50AM
UK Regulatory
TIDMDPH
RNS Number : 3558N
Dechra Pharmaceuticals PLC
23 September 2019
23 September 2019
Dechra(R) Pharmaceuticals PLC
(Dechra or the Company)
Notification and public disclosure of transactions by
persons discharging managerial responsibilities (PDMRs)
Dechra Pharmaceuticals PLC announces that on 19 September 2019,
the following PDMRs exercised nil cost options over ordinary shares
of 1p each in the Company. The options were granted to them on 19
September 2016 pursuant to the Dechra Pharmaceuticals PLC Long Term
Incentive Plan (the LTIP). The exercise of the options was subject
to the achievement of performance conditions which were satisfied
in full so that the options vested at 100%. Ian Page sold
sufficient shares (acquired pursuant to the exercise) in order to
fund the resulting tax liability and Tony Griffin sold all of the
shares (acquired pursuant to the exercise).
Name Capacity Options Shares Sale Price Total beneficial Percentage
Exercised Sold per share shareholding of issued
following this share capital
announcement
Ian Page Director 73,260 34,536 GBP27.893745 625,374 0.608%
Tony Griffin Director 20,858 20,858 GBP27.893745 70,606 0.069%
The Notification of Dealing Forms set out below are provided in
accordance with the requirements of the EU Market Abuse
Regulation.
Notification of Dealing Form
1. Details of the Person Discharging Managerial Responsibility
("PDMR")/person closely associated with them ("PCA")
a) Name Ian Page
---------------------------------- ---------------------------------------
2. Reason for the notification
---------------------------------------------------------------------------
a) Position/status Director/PDMR
---------------------------------- ---------------------------------------
b) Initial notification/ Initial Notification
amendment
---------------------------------- ---------------------------------------
3. Details of the Issuer
---------------------------------------------------------------------------
a) Name Dechra Pharmaceuticals PLC
---------------------------------- ---------------------------------------
b) LEI code 213800J4UVB5OWG8VX82
---------------------------------- ---------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
---------------------------------------------------------------------------
a) Description of Ordinary Shares of 1 pence each
the financial
instrument
ISIN: GB0009633180
Identification
code
---------------------------------- ---------------------------------------
b) Nature of the Exercise of 73,260 options under the
transaction Company's Long Term Incentive Plan
---------------------------------- ---------------------------------------
c) Price(s) and volumes(s) Price(s) Volume(s)
GBPNil Cost 73,260
---------------------------------- ---------------------- ---------------
d) Aggregated information
* Aggregate volume
N/A
* Price
---------------------------------- ---------------------------------------
e) Date of the transaction 2019.09.19
---------------------------------- ---------------------------------------
f) Place of the transaction Outside a trading venue
---------------------------------- ---------------------------------------
1. Details of the Person Discharging Managerial Responsibility
("PDMR")/person closely associated with them ("PCA")
a) Name Ian Page
--------------------------------- ------------------------------------------
2. Reason for the notification
-----------------------------------------------------------------------------
a) Position/status Director/PDMR
--------------------------------- ------------------------------------------
b) Initial notification/ Initial Notification
amendment
--------------------------------- ------------------------------------------
3. Details of the Issuer
-----------------------------------------------------------------------------
a) Name Dechra Pharmaceuticals PLC
--------------------------------- ------------------------------------------
b) LEI code 213800J4UVB5OWG8VX82
--------------------------------- ------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
-----------------------------------------------------------------------------
a) Description of Ordinary Shares of 1 pence each
the financial
instrument
ISIN: GB0009633180
Identification
code
--------------------------------- ------------------------------------------
b) Nature of the Partial sale of shares obtained under
transaction the Company's Long Term Incentive Plan
to satisfy tax liability
--------------------------------- ------------------------------------------
c) Price(s) and volumes(s) Price(s) Volume(s)
GBP27.893745 34,536
--------------------------------- ------------------------ ----------------
d) Aggregated information
* Aggregate volume 34,536
GBP27.893745
* Price GBP963,338.38
* Total
--------------------------------- ------------------------------------------
e) Date of the transaction 2019.09.20
--------------------------------- ------------------------------------------
f) Place of the transaction London Stock Exchange
--------------------------------- ------------------------------------------
1. Details of the Person Discharging Managerial Responsibility
("PDMR")/person closely associated with them ("PCA")
a) Name Tony Griffin
------------------------------------- ---------------------------------------
2. Reason for the notification
------------------------------------------------------------------------------
a) Position/status Director/PDMR
------------------------------------- ---------------------------------------
b) Initial notification/ Initial Notification
amendment
------------------------------------- ---------------------------------------
3. Details of the Issuer
------------------------------------------------------------------------------
a) Name Dechra Pharmaceuticals PLC
------------------------------------- ---------------------------------------
b) LEI code 213800J4UVB5OWG8VX82
------------------------------------- ---------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
------------------------------------------------------------------------------
a) Description of Ordinary Shares of 1 pence each
the financial
instrument
ISIN: GB0009633180
Identification
code
------------------------------------- ---------------------------------------
b) Nature of the Exercise of 20,858 options under the
transaction Company's Long Term Incentive Plan
------------------------------------- ---------------------------------------
c) Price(s) and volumes(s) Price(s) Volume(s)
GBPnil 20,858
------------------------------------- ------------------ -------------------
d) Aggregated information
* Aggregate volume
N/A
* Price
------------------------------------- ---------------------------------------
e) Date of the transaction 2019.09.19
------------------------------------- ---------------------------------------
f) Place of the transaction Outside a trading venue
------------------------------------- ---------------------------------------
1. Details of the Person Discharging Managerial Responsibility
("PDMR")/person closely associated with them ("PCA")
a) Name Tony Griffin
--------------------------------- ----------------------------------------------
2. Reason for the notification
---------------------------------------------------------------------------------
a) Position/status Director/PDMR
--------------------------------- ----------------------------------------------
b) Initial notification/ Initial Notification
amendment
--------------------------------- ----------------------------------------------
3. Details of the Issuer
---------------------------------------------------------------------------------
a) Name Dechra Pharmaceuticals PLC
--------------------------------- ----------------------------------------------
b) LEI code 213800J4UVB5OWG8VX82
--------------------------------- ----------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
---------------------------------------------------------------------------------
a) Description of Ordinary Shares of 1 pence each
the financial
instrument
ISIN: GB0009633180
Identification
code
--------------------------------- ----------------------------------------------
b) Nature of the Sale of shares obtained under the Company's
transaction Long Term Incentive Plan.
--------------------------------- ----------------------------------------------
c) Price(s) and volumes(s) Price(s) Volume(s)
GBP27.893745 20,858
--------------------------------- --------------------------- -----------------
d) Aggregated information
* Aggregate volume 20,858
GBP27.893745
* Price GBP581,807.73
* Total
--------------------------------- ----------------------------------------------
e) Date of the transaction 2019.09.20
--------------------------------- ----------------------------------------------
f) Place of the transaction London Stock Exchange
--------------------------------- ----------------------------------------------
For further information, please contact:
Melanie Hall, Company Secretary
Telephone number: 01606 814730
About Dechra
Dechra is a global specialist veterinary pharmaceuticals and
related products business. Our expertise is in the development,
manufacture, and sales and marketing of high quality products
exclusively for veterinarians worldwide. Dechra's business is
unique as the majority of its products are used to treat medical
conditions for which there is no other effective solution or have a
clinical or dosing advantage over competitor products. For more
information please visit: www.dechra.com
Trademarks
Dechra and the Dechra "D" logo are registered trademarks of
Dechra Pharmaceuticals PLC.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHCKNDQPBKDOCB
(END) Dow Jones Newswires
September 23, 2019 11:50 ET (15:50 GMT)
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From Apr 2024 to May 2024
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From May 2023 to May 2024